HR 4553
116th Congress
House
Health
Cardiovascular and respiratory health
Drug safety, medical device, and laboratory regulation
Drug therapy
Infectious and parasitic diseases
Adding Epidemic Diseases to the FDA Priority Review Voucher Program Act
Introduced: September 27, 2019
Introduced by:
Boyle, Brendan F.
Democratic
· Pennsylvania
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 30, 2019
Referred to the Subcommittee on Health.
Sep 27, 2019
Referred to the House Committee on Energy and Commerce.
Sep 27, 2019
Introduced in House
Plain-English summary
Adding Epidemic Diseases to the FDA Priority Review Voucher Program Act
This bill expands the priority-review voucher program for tropical diseases to include Middle East respiratory syndrome, Nipah virus, and Rift Valley fever. A voucher entitles the holder to have a future new drug or biological product application acted upon by the Food and Drug Administration within six months.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2